Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer

New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer

(2016) Min-Sun Jin et al.   TUMOR BIOLOGY

Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer

(2016) Ji-Yeon Kim et al.   Cancer Research and Treatment

Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer

(2015) X. Zhu et al.   BREAST CANCER RESEARCH AND TREATMENT

Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer

(2015) Nami Yamashita et al.   Clinical Breast Cancer

Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival

(2015) Aye A. Thike et al.   HISTOPATHOLOGY

Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer

(2015) Tetsuyo Maeda et al.   Medical Molecular Morphology

Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer

(2014) Jung Eun Choi et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic significance of Bcl-2 expression in non-basal triple-negative breast cancer patients treated with anthracycline-based chemotherapy

(2014) Jung Eun Choi et al.   TUMOR BIOLOGY

p53 in breast cancer subtypes and new insights into response to chemotherapy

(2013) Philippe Bertheau et al.   BREAST

Distincttumor protein p53mutants in breast cancer subgroups

(2012) Anne Dumay et al.   INTERNATIONAL JOURNAL OF CANCER

Loss of Heterozygosity at BRCA1 Locus Is Significantly Associated with Aggressiveness and Poor Prognosis in Breast Cancer

(2011) Satoko Okada et al.   ANNALS OF SURGICAL ONCOLOGY

p53 Status Identifies Two Subgroups of Triple-negative Breast Cancers with Distinct Biological Features

(2011) E. Biganzoli et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Prognostic Significance of Basal Markers in Triple-negative Breast Cancers

(2009) Jun Mo Kim et al.   Journal of Breast Cancer

Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer

(2009) Aye Aye Thike et al.   MODERN PATHOLOGY

Expression of BRCA1 protein in breast cancer and its prognostic significance

(2008) Emad A. Rakha et al.   HUMAN PATHOLOGY